| Prev Close | 64.01 |
| Open | 64.48 |
| Day Low/High | 64.02 / 64.89 |
| 52 Wk Low/High | 57.16 / 75.59 |
| Volume | 1.00M |
Centene Corporation (CNC)
64.73
0.72
1.10
NYSE
| Exchange | NYSE |
| Shares Outstanding | 583.04B |
| Market Cap | 38.08B |
| P/E Ratio | 16.85 |
| Div & Yield | N.A. (N.A) |
Latest News
Jim Cramer: The Bears Are Fooling Themselves
Let's look at the many positive story lines out there -- which having nothing to do with the Fed -- and what they mean for investors.
Centene Finally Looks Ready to Make a Move Higher
Let's review the charts and indicators.
Jim Cramer: Trust Your Instincts Not the Direction of the Stock
The next time you are shaken out because of the action I need you to remember these examples.
Centene Fantastic Growth, Bargain Valuation
This is a company with a $34 billion market cap. But few have even heard of it.
Centene Shares Appear to Be Weakening
The stock of the health plan provider has not been able to show any sustained strength.
Centene Charts Remain Weak and Vulnerable
Let's review the charts and indicators.
Amazing Small-Caps, Minimum Wage, An Unhealthy Survey, Trading Nvidia, Chegg
The Russell 2000 has now soared 16% year to date, nearly twice the Nasdaq Composite's 8.5% move.
Jim Cramer: Here Are the Biden Stocks
As power has changed hands in the White House, we can expect these names -- and themes -- to benefit.
Centene Is Still Not Showing Us the Right Stuff
Here's our analysis and trading strategy for CNC shares.
Decision Time -- for These Stocks, at Least
While the market appears to be enjoying the election results (so far), here's my take on electric vehicles, health care, metals and restaurants.
Jim Cramer: Let's Bust These Election Myths
These are the top five misconceptions about presidential elections -- and the stocks that you should look at right now.
Sometimes the Path of the Most Resistance Is the Best One
Here I'll show you why the best buys are often only available when you're too scared to buy them.
Centene Could Decline Further as Broader Market Weakens
Let's check the charts of the health plan provider.
Jim Cramer: You Heard the Ugly of the Debate. Here's the Good.
Neither candidate seems to be the enemy of the market -- at least not yet.
Refuse to Be Gaslighted by Market Pundits
Follow fundamentals and ignore the attempts to gaslight you into not believing your own projections.
Here's a Healthy Investing Opportunity
Centene is a $110 billion in revenue company you've probably never heard of. Here's how to play it.
Still Waiting for Centene to Make an Upside Move
Technical analysis and trading strategy for the healthcare plan provider.
Jim Cramer: Why You Shouldn't Expect the Market to Get Clobbered Again Monday
Let's go over the confluence that allowed us to advance after a brief dip down in the morning.
Centene Stock Looks a Little Vulnerable Right Now
Trade carefully.
Wait for it: Centene Could Break Out to New Highs
Overall the charts of CNC are constructive but I would still want to buy strength.
Small-Caps Roar, Bets Against the Market, Trading Nvidia
Money movers are not buying protection for individual names, but they are starting to bet against the market en masse, while the Russell 2000 ran up 4% on Monday.
Jim Cramer: One Thing This Market Doesn't Lack Is Confidence
You can sell any stock that's up and take that money to the bank and no one will say, "sorry that was made off of euphoria, we can't take it."
Centene: What's Next for Shares of the Health Plan Provider?
Let's see what the charts look like the day after the State of the Union address.
Jim Cramer: Here's Why the Market Hasn't Stopped Rallying
These are the 10 reasons why we keep going up, despite all the bad news.
Drug Companies Are a Political Football, Trading Amgen: Market Recon
The nation enters an electoral season. The drug companies for the most part, have no friends on either side of the aisle.
